What is FAP Kdpharma Group
Familial Adenomatous Polyposis (FAP) is a hereditary condition that results in the early development of polyps and colorectal cancer that could starts at the early age of 12 years old. FAP is considered as an orphan disease, with a prevalence of 0,6/1,0 out of 10.000. Caused by germline mutations in the APC gene it is characterized by the development of hundreds to thousands of polyps and carriers of the APC gene mutation, if not treated appropriately, will develop colorectal cancer. Unfortunately at the moment there is no safe treatment available.
![](https://www.globaldata.com/store/wp-content/uploads/sites/2/2022/04/Familial-Adenomatous-Polyposis-Drugs-Market-by-Targets-700x338.png)
Familial Adenomatous Polyposis Drugs in Development by Stages
![](https://via.tt.se/data/images/00731/737ae5dd-2b51-4e1b-a688-1362281152c3.jpg/social)
KD Pharma Group & SLA Pharma Initiate Clinical Trial For COVID-19
![](https://di9mr54a05a64.cloudfront.net/api-smartevents.expoplatform.com/image/MTY2Nzk4ODkxMTYzNmI3ZGFmNWRlMDU=.png)
KD Pharma
![](https://www.kdpharmagroup.com/sites/default/files/inline-images/Picture2.png)
News Kdpharma Group
![](https://www.kdpharmagroup.com/sites/default/files/2020-10/nutra.jpg)
Leader in Pharmaceutical Omega 3 Manufacturing
KD Pharma Group
![](https://article.innovamarketinsights360.com/articleimgs/article_images/637225532217883975lab%20research%20%5B740x740%5D.jpg)
Fatty acid and sweet wormwood on road to clinical trials for COVID-19
KD Pharma Group - Crunchbase Company Profile & Funding
KD Pharma Group
SLA Pharma
Justin Slagel on LinkedIn: BIO-Europe Spring 2023
![](https://m.media-amazon.com/images/I/71IOQnnawVL.jpg)
Allergy Research Group DHEA 25mg Supplement - Hormone
![](https://www.capiton.de/wp-content/uploads/2021/01/h_EMS-480x250.png)
KD Pharma Group - capiton
![](https://www.slapharma.com/wp-content/uploads/2019/04/SLA-logo@3x-1-300x231.png)
SLA Pharma AG & KD Pharma Group COVID-19 Clinical Trial Approved